Sightera Biosciences
Sightera Biosciences is a pre-clinical stage biotech company that integrates patient-derived drug screening data with an advanced AI-drug design engine to develop innovative small molecules for oncology and regenerative medicine. Their unique approach combines phenotypic patient-derived screening data with AI-driven design algorithms to create novel therapeutic candidates, optimizing their biological activity through iterative testing. With a focus on immuno-oncology and regenerative medicine, Sightera aims to enhance drug discovery efficiency while reducing R&D costs by 60%. Their proprietary technology and multi-featured drug design provide a strategic advantage in developing a diverse library of small molecules with potent properties for various applications.
Sightera Biosciences
Sightera Biosciences is a pre-clinical stage biotech company that integrates patient-derived drug screening data with an advanced AI-drug design engine to develop innovative small molecules for oncology and regenerative medicine. Their unique approach combines phenotypic patient-derived screening data with AI-driven design algorithms to create novel therapeutic candidates, optimizing their biological activity through iterative testing. With a focus on immuno-oncology and regenerative medicine, Sightera aims to enhance drug discovery efficiency while reducing R&D costs by 60%. Their proprietary technology and multi-featured drug design provide a strategic advantage in developing a diverse library of small molecules with potent properties for various applications.